BioFocus has announced that it has
expanded a collaboration with the Usher III Initiative, Inc., a non-profit
organization focused on developing treatments for Usher syndrome type III, a
rare genetic disorder that causes the loss of hearing and vision.
BioFocus
and the Usher III Initiative began their collaboration in July 2010 with
BioFocus performing an integrated drug discovery program encompassing medicinal
chemistry, ADME and biological sciences, aiming at a small-molecule therapy for
Usher syndrome type III. Under the terms of the extended agreement,
BioFocus will further advance the project with the objective of delivering a
pre-clinical candidate.
"The
extension of this collaboration is testament to the quality of the scientific
input that BioFocus offers its clients," said Dr Chris Newton, Senior Vice
President Galapagos Services. "The quality of the science at BioFocus
enables it to sustain its position as a premier provider in drug discovery
services."
"We
are pleased with the progress BioFocus has made thus far on discovering
potential therapies for Usher syndrome. BioFocus' approach fits very well
with our aim of getting therapies into the clinic quickly and efficiently,"
said Dr. David Saperstein, Scientific Director, Usher III Initiative,
Inc.
About Usher III Initiative, Inc.
The Usher III Initiative, Inc. is a
non-profit organization dedicated to developing cures for blindness associated
with Usher syndrome type III. The Initiative funds research at
universities and contract research organizations in the United States and
Europe. More info is available at:
www.usheriii.org
About
BioFocusBioFocus
delivers drug discovery solutions through a comprehensive platform run by
dedicated teams with a track record in gene-to-clinical candidate
discovery. BioFocus' offering includes target discovery in human primary
cells, focused as well as diverse compound libraries,
in vitro and
cell-based screening, structural biology, medicinal chemistry and ADME/PK
services, supported by unique chemogenomic and informatics tools. As a
service division of Galapagos, BioFocus has over 210 employees with research
facilities in three countries. More info at:
www.biofocus.com
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.